Malaysian Health Technology Assessment Section

Good day everyone! Is it true that a portable device using signature wave technology analysing hair sample can provide real time health insight within 15 minutes? Let's check it out! #MaHTAS #technologyreview #HealthTechnologyAssessment #kementeriankesihatanmalaysia

Join us for our next session of Training on CPG for Primary Care Providers on Acne Vulgaris 📅 Date: Saturday, 8 March 2025 🕒 Time: 1.30 pm – 4.00 pm Our esteemed speakers will delve into the latest guidelines and best practices on management of acne vulgaris: 👩⚕️ Dr. Norliza Muksan, Consultant Family Medicine Specialist 👩⚕️ Dr. Evelyn Yap Wen Yee, Consultant Dermatologist 👩⚕️ Dr. Latha Selvarajah, Consultant Dermatologist With the guidance of our moderator, Dr. Azura Mohd Affandi, Consultant Dermatologist, this training will equip you with the necessary knowledge and skills to address this health issue. Don't miss the insights from Dato Dr. Parmjit Singh, PPSMMA Chairman 2024/2025, on the importance of staying updated with clinical practices in the rapidly evolving medical landscape. Click on the link below or scan the QR code in the poster to register now and be a part of this crucial discussion. https://lnkd.in/gZdhDFVy CPD points will be awarded.

MAHTAS has long recognized the importance of qualitative research in shaping evidence-based healthcare policies. Recently, we published a paper on public and patient involvement (PPI) in decision-making regarding continuous glucose monitoring systems (CGMS) for diabetes. This study incorporated extensive focus group discussions (FGDs) to address policy questions, explore deliberative processes, and ensure stakeholder engagement in health technology assessments. In strengthening our capacity for qualitative research, we had the opportunity to participate in an intensive workshop on Qualitative Research, ARC & Analysis with Assoc. Prof. Ts. Dr. Mohd Zairul bin Mohd Noor at the Pusat Kecemerlangan Kesihatan Mental Kebangsaan (NCEMH). The workshop provided a comprehensive exploration of qualitative research, beginning with its foundational principles and progressing into structured methodologies such as thematic analysis and the ARC Method to systematically extract insights from data. Participants gained practical skills in preparing, coding, and analyzing qualitative data, focusing on developing themes and visualizing relationships to uncover meaningful patterns. A hands-on session with ATLAS.ti further reinforced data management and interpretation techniques, ensuring efficient handling of qualitative findings. Discussions on interpretation, reporting, and maintaining research credibility emphasized the importance of methodological rigor, particularly in integrating qualitative insights with quantitative data to enhance policy recommendations and healthcare decision-making. MAHTAS has actively applied these methodologies in previous assessments, including the CGMS for diabetes study, where FGDs played a key role in gathering public and patient perspectives. This approach ensures that policy decisions are patient-centered, contextually relevant, and grounded in real-world experiences. This workshop further solidified our expertise in qualitative research, equipping us with practical tools to improve HTA evaluations and evidence-based policymaking. Appreciation is extended to Dr. Zairul for his expert guidance and to all participants for the enriching discussions and knowledge-sharing throughout the sessions.

🌎 Rare Disease Day | 28 February 2025 🌎 Did you know that 300 million people worldwide are living with a rare disease? 💜 Around 72% of rare diseases are genetic, and 70% of genetic rare diseases start in childhood. At MaHTAS, we support all efforts to raise awareness, improve access to healthcare, and enhance research for rare diseases. Let's work together for a better future! 💙💚💜 #RareDiseaseDay #MaHTAS #HealthForAll #RareButNotAlone #StrongerTogether

Priority Setting Exercise for Health Technology Assessment (HTA) topics for 2025-2026 Manggis Meeting room, Block E3, Nutrition Division, Ministry of Health, Malaysia. On 25 February 2025, the Priority Setting Exercise for Health Technology Assessment (HTA) topics for 2025-2026 was successfully conducted. The meeting was attended by members of the Technical Advisory Committee on Health Technology Assessment (TACHTA) and the Technical Advisory Committee on Health Technology Evaluation and Evidence (TACHTEE), who played a crucial role in evaluating and prioritising key healthcare issues. Prioritising topics for assessment is an essential step in the workprocess, designed to inform decisions and resources allocation that maximizes health gain. This process ensures efficient use of resources and aligning assessments with national priorities. During this session, 24 identified topics following request from stakeholders nationwide were carefully reviewed. Insightful deliberation conducted and members collectively agreed on the prioritisation results. This transparent, systematic process ensures that HTA efforts focus on the most pressing health technologies, considering pertinent factors such as disease burden, effectiveness and safety issues of the technologies, cost-implications to the healthcare system, resources implications including infrastructure, manpower and involvement of other services; as well as availability of competing technology. The outcomes of this session will be presented at the Technical Advisory Committee Meeting on 15 May 2025, followed by the HTA & Clinical Practice Guidelines Council Meeting planned on 10 June 2025. A big thank you to all participants for their valuable contributions! This process help to ensure that stakeholder decisions are based on the best available evidence, to provide greatest impact to population health and sustaining the healthcare system. #HTA #HealthTechnologyAssessment #PrioritySettingExercise #MaHTAS #kementeriankesihatanmalaysia

🔍 Li-ESWT: A Treatment for Chronic Prostatitis/Chronic Pelvic Pain Syndrome Did you know that Low-Intensity Extracorporeal Shock Wave Therapy (Li-ESWT) can help relieve symptoms of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)? It has been shown to improve symptoms and quality of life, is generally safe, and procedure must be performed by trained professionals. Check out the infographic to learn more! 📊✨ #MaHTAS #HealthTech #LiESWT #ChronicPain

✨ Happy Friyay! ✨ Friday is a time to reflect, celebrate achievements, and finish strong. Let's wrap up the week with gratitude and motivation! 💪🎉 #HappyFriday #FridayMotivation #EndTheWeekStrong #MaHTAS

Hello everyone! Want to know about the success of HTA activities? What contributions has MaHTAS made on a global scale? Check it out in the HTAi Review | February 14, 2025 : https://lnkd.in/g7zchkH7 Even more exciting updates inside! Find out more here: ✨ HTA News from Around the World https://lnkd.in/gA3zPtyb ✨ Patient Perspectives on Continuous Glucose Monitoring System (CGMS) for Diabetes in Malaysia: A Key Voice in Health Technology Assessment (HTA) for Decision-Making https://lnkd.in/gUA9RX2p Happy reading!

Technical Advisory Committee HS Meeting 1/2025 19 February 2025 The first Technical Advisory Committee (TAC) Horizon Scanning meeting of 2025 was successfully held today, chaired by Dr. Razmin, Consultant Pathologist from HKL. This session was particularly engaging, with committee members from our national advisors, clinicians, experts, and regulators from diverse sectors to discuss and share their expertise on five technologies and emerging technologies. The meeting fostered valuable in-person interactions and dynamic discussions, facilitating rich knowledge exchange and actionable insights. After thorough deliberation and scoring, three technologies were selected for further evaluation as TechBrief reports. A heartfelt thank you to all committee members for their insightful contributions, dedication, and active participation. #mahtas #horizonscanning #kementeriankesihatanmalaysia

📢 Join us for our Rare Disease Day Webinar! 📢 🔹 Why do we need a new paradigm for evidence generation and assessment in rare disease technologies (RDTs)? 🔹 🗓 Date: 27 February 2025 | ⏰ Time: 14:00 - 15:30 CET 🔹 Register here: https://lnkd.in/e5hswysD Rare diseases present unique challenges in evidence generation, making traditional health technology assessment (HTA) approaches difficult to apply. This multi-stakeholder discussion will explore: ✅ The current barriers in evidence assessment for RDTs ✅ Key findings from a new survey on evidence assessment frameworks ✅ Insights from an international patient expert in HTA scientific advice ✅ Emerging initiatives to advance evidence assessment for better healthcare decision-making Whether you're involved in policy, research, patient advocacy, or HTA, this is an opportunity to engage with experts shaping the future of rare disease evidence assessment. Panelists: Dorota Zgodka, Ph.D. Alicia Granados, MD, PhD PHFleur ChandlerTanya Collin-Histed Sean TunisAnja Schiel Diana Sinkevich Kit Roes 🎤 Don’t miss this important conversation—register today and be part of the change! #RareDiseaseDay #HTA #EvidenceGeneration #HealthcareInnovation #PatientCentricity